Metraipolis › archive › dc_9cebcafad474
USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma — Europe PMC PMID:41820949
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41820949
- DOI
- 10.1186/s13046-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T11:18:15.256Z
- SHA-256 of the archived text
bc2fb9fd8594fb1a248506a62c33885445b7cd62c4d5d63c9d0bd5e66a637602- Stable URL of this page
https://metraipolis.com/documento/dc_9cebcafad474
How to cite
USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma — Europe PMC PMID:41820949 — Europe PMC (en), https://europepmc.org/article/MED/41820949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9cebcafad474 (Metraipolis archive dc_9cebcafad474, sha256 bc2fb9fd8594fb1a248506a62c33885445b7cd62c4d5d63c9d0bd5e66a637602)
BibTeX
@misc{dc9cebcafad474,
title = {USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma — Europe PMC PMID:41820949},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41820949},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9cebcafad474; sha256 bc2fb9fd8594fb1a248506a62c33885445b7cd62c4d5d63c9d0bd5e66a637602},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41820949. Agents can read the archived copy with the MCP tool read_document.